April 11, 2013 | |
21 minutes | |
Scott Lippman, MD, /search?speakers= | |
Scott Lippman, MD, is a professor of medicine at UC San Diego and holds the Chugai Pharmaceutical Chair in Cancer. He has participated in the national leadership of clinical/translational research planning and development within the NCI Cooperative Group setting and currently sites on the National Institutes of Health (NIH) Clinical Trials/Translational Research Advisory Committee.